Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

All the assumptions are that the news will be awesome but if it is bad news no one can sell fast enough.

https://clinicaltrials.gov/archive/NCT02401750/2015_04_02/changes

The study is designed to evaluate the safety and efficacy of oxycodone/naltrexone 1.5 mg and 3.0 mg versus placebo. During the blinded phase of the study(inpatient portion) the dosing regimen is 1 capsule containing 15 mg Oxycodone Hydrochloride with 1.5 mg Naltrexone Hydrochloride or 3.0 mg Naltrexone Hydrochloride, or placebo taken with 4 to 6 ounces (oz) of water every 6 hours (q6h) for 48 hours following the first dose (Multiple-dose Period) while in-house. Then for the open-label phase of the study (outpatient portion) dosing will occur every 4 to 6 hours prn with 15 mg Oxycodone/1.5 mg Naltrexone. The active and placebo study medications will appear identical.

OxyIR 15mg q6h scheduled x 48 hours vs. placebo.


Yeah, I assume the news will be awesome.